Delivery Order SPE2DB24D2212-SPE2DB25FHQUK
Award Date 9/12/25
Potential Completion Date 9/15/25
Potential Value $94K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count packages) under a firm fixed-price contract valued at $3,337.56. The order was competitively awarded without set-aside provisions and is scheduled for completion by July 25, 2025. Multaq is an antiarrhythmic medication used in the treatment of atrial fibrillation, reflecting the pharmaceutical distributor's role in supplying critical medications to federal...
- The Defense Logistics Agency awarded a $3,296.73 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Multaq 400 mg tablets (60 count). This firm fixed-price, non-set-aside contract is scheduled for completion by September 9, 2025, with fulfillment occurring at the contractor's Conshohocken, Pennsylvania facility. Multaq is an antiarrhythmic medication used in the treatment of atrial fibrillation, representing a critical pharmaceutical supply for military and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,947.74 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg on September 2, 2025, with completion scheduled for September 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Multaq is an antiarrhythmic medication used in the treatment of atrial fibrillation, supporting the military...
- The Defense Logistics Agency awarded a delivery order valued at $10,061.44 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on August 28, 2025, with completion scheduled for August 29, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. Multaq is a cardiovascular medication used in the treatment of atrial fibrillation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $11,496.80 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Multaq 400 mg tablets (60-count packages). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract calls for delivery by August 6, 2025, and performance will occur at the contractor's Conshohocken facility. This delivery...
- The Defense Logistics Agency awarded a $51,938.18 delivery order to AmerisourceBergen Drug Corp for 60-tablet units of Multaq 400 mg tablets, a pharmaceutical product used in cardiac arrhythmia management. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 13, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at approximately $25.5K to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by July 30, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Multaq is a cardiac antiarrhythmic medication used in the treatment of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Multaq 400 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $16,325.07. This non-set-aside award is to be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. Multaq is a cardiac antiarrhythmic medication used in the treatment of atrial...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $19,665.68 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units). The contract, which is a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA, was competitively awarded without set-aside designation and is scheduled for completion by September 3, 2025. Multaq is an antiarrhythmic medication used in military and veteran healthcare systems,...
- The Defense Logistics Agency awarded a delivery order valued at approximately $7K to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units). This competitively awarded, firm fixed-price contract with no set-aside designation was executed on July 28, 2025, with an ultimate completion date of July 29, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...